Genmab reported 3M in Interest Expense on Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
Amarin AMRN:US $ 0.03M 0.02M
Amgen AMGN:US $ 281M 4M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Fresenius Medical Care FME:GR € 83M 8M
Genmab GEN:DC 3M 0
Immunogen IMGN:US $ 3.58M 1.09M
Insmed INSM:US $ 10.32M 2.76M
Lonza Group LONN:SW 29M 7M
Novartis NOVN:VX 201M 1000K
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M